Maj Mel Mann, Ret., MBA, M.Ed, Patient Advocate🎗️
@MelDMann
WORLD’S LONGEST LIVING GLEEVEC & Tyrosine Kinase Inhibitor TKI Survivor, 29 Yr #CML Survivor, Army Ret, CONNECT IF YOU’RE CONNECTED TO CANCER OR CLINICAL TRIALS
ID:47336979
http://g.co/kgs/SgCVaQ5 15-06-2009 13:42:49
35,6K Tweets
502,2K Followers
259,2K Following
Follow People
A Clinical Trial Saved My Life: Surviving Chronic Myeloid Leukemia blackdoctor.org/mel-mann-survi… via BlackDoctor
In our most recent #CUREConnect , a CURE® reader asked how to manage #FearofRecurrence 15 years into #survivorship .
Here’s what retired nurse practitioner Jody Pelusi from Arizona Oncology (Arizona Oncology) had to say:
curetoday.com/view/how-to-fa…
Thank you for visiting Broad, Dr. Monica M. Bertagnolli! It was an honor hosting the AllofUsResearch team, and we are extraordinarily proud to be partners in the program.
Spread love and support on #AMLWorldAwarenessDay ! ❤️👇 Join us in spreading awareness and HOPE this year!
❤️ Our investment in game-changing breakthroughs like our Beat AML® Master Clinical Trial is improving outcomes. Because of this trial, some patients with a prognosis of…
“I’m sorry.”
The incredible stories from brave people around the country about #workplace #abuse and #trauma are finally being told!
Our mission is clear.
To see the entire 1st episode:
youtu.be/YHD9N4lgnfo?si…
New YouTube show
MySilenceIsNotForSale
#MySilenceIsNotForSale …
Dasatinib + Venetoclax is safe & effective in newly diagnosed #CML in CP, but no better than single-agent dasatinib; longer follow-up needed to evaluate impact on TFR:
MD Anderson Cancer Center #Leukemia
ACS Journal Cancer
acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…
#NationalMinorityHealthMonth takes all of us standing together and speaking up to address racial and ethnic minority health disparities. Raise awareness and offer solutions. ow.ly/KvXb50RgAGB